Cancer Cytopathology

Papers
(The TQCC of Cancer Cytopathology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Issue Information44
Diagnostic terminology for benign/low‐risk tumors on renal cytology38
The International Academy of Cytology Yokohama System for Reporting Breast Cytopathology showed improved diagnostic accuracy35
34
30
27
Issue Information25
Mucoepidermoid carcinoma: Analysis of 76 cytologic cases and correlation with histologic grade23
Issue Information22
Issue Information22
21
20
Cytologic diagnosis of papillary renal neoplasm with reverse polarity19
Retrospective analysis of HPV infection: Cotesting and HPV genotyping in cervical cancer screening within a large academic health care system19
A rapid turnaround time workflow for a cytological liquid biopsy assay using FNA supernatant specimens19
A distinctive cytomorphological feature of interstitial pneumonia–related lung adenocarcinoma: The potential issues and solutions in practical diagnosis19
Mucinous‐appearing contamination of serous effusions by sodium carboxymethyl cellulose from suction canister lids19
Counseling gap may worsen endometrial cancer disparities in Black women18
Single BRAFV600E mutation is not associated with aggressive biological behavior in adolescent and pediatric papillary thyroid carcinoma17
Less is more meets do more with less: Exploring differences in thyroid FNA molecular testing between Asian and Western practices17
Turning Heads: A Much‐Needed Project in Empathy16
16
Issue Information16
Cytologic risk stratification of medullary thyroid carcinoma: Does it make the grade?16
The important role of routine cytopathology in pediatric precision oncology15
Copy number variations identified in thyroid FNA specimens are associated with Hürthle cell cytomorphology15
Understanding the “zombie cells” that won’t die15
Issue Information14
14
13
Growing cancer risks on a warming planet13
From observation to judgment: Making sense of milestones 2.0 for cytopathology13
Are we on track for diagnosing high‐grade urothelial carcinoma with a minimum quantity of five malignant cells in lower tract specimens? Critical analysis of The Paris System Quantitation Criteria13
Leveraging archival cerebrospinal fluid samples for genetic insights from cell‐free DNA13
The International Academy of Cytology Yokohama System for Reporting Breast Fine‐Needle Aspiration Biopsy Cytopathology: Recent research findings and the future12
How the Milan System for Reporting Salivary Gland Cytopathology works in cytopathology practice: Meta‐analysis of prospective studies and comparison with retrospective studies12
Detection of effusion tumor cells under different storage and processing conditions12
Artificial intelligence and cytopathology: Where are we heading?12
Preclinical medical students and pathologists: Departing from the text12
Incorporating cytologic adequacy assessment into precision oncology workflow using telepathology: An institutional experience12
Thin‐layer cervical sample evaluation: Conventional light microscopy versus digital whole‐slide imaging11
Spotlight: Rising stars in cytology11
Homage to Georgios Papanikolaou: A pilgrimage to his birthplace11
11
An old friend, a new insight: Calcitonin measurement in serum and aspiration needle washout fluids significantly increases the early and accurate detection of medullary thyroid cancer11
A disturbing link between cancer and suicide11
Generic cancer drugs are still in short supply10
Cancer‐aiding elements begin illuminating the genome’s “dark matter”10
Exploring the atypia of undetermined significance: Malignant ratio, ThyroSeq v3 positive call rate, molecular‐derived risk of malignancy, and risk of malignancy as possible quality metric tools in thy10
A simplified molecular method to detect high‐risk HPV using the Aptima HPV assay on head and neck FNA smears10
The utility of next‐generation sequencing in challenging liver FNA biopsies10
The negative outlook: Long‐term follow up of ThyroSeq negative and low‐risk nodules10
Development and validation of a decision tree for distinguishing pulmonary adenocarcinomas with mucinous features and metastatic colorectal adenocarcinoma10
Atypia of undetermined significance in thyroid cytology: Nuclear atypia and architectural atypia are associated with different molecular alterations and risks of malignancy9
Utility of an anchored multiplex polymerase chain reaction‐based fusion assay for diagnosis of soft tissue tumors in cytology9
Rapid on‐site evaluation (ROSE) of image‐guided FNA specimens improves subsequent core biopsy adequacy in clinical trial patients: The impact of preanalytical factors and its correlation with survival9
Erratum to “p53 expression in cytology samples may represent a marker of early‐stage cancer”9
Rapid On‐site Evaluation Practice Variability Appraisal (ROSE PETAL) survey9
The unexpected costs of “free” preventive care9
Erratum to “Papillary lesions of the breast: A systematic evaluation of cytologic parameters”9
Molecular analysis using SalvGlandDx improves risk of malignancy estimation and diagnosis of salivary gland cytopathology: An exploratory multicenter study9
9
HPV persistence after cervical surgical excision of high‐grade cervical lesions9
Cervical cancer prevention in the United States—where we've been and where we're going: The American Cancer Society Primary HPV Screening Initiative9
The fall of Roe and the growing fallout for medical care8
Diagnostic performance of fine‐needle aspiration in soft tissue tumors: Application of the World Health Organization System for Reporting Soft Tissue Cytopathology and risk of malignancy assessment8
Future initiatives and approaches to reducing the impact of lung cancer8
Evaluation of an artificial intelligence algorithm for assisting the Paris System in reporting urinary cytology: A pilot study8
8
Thank You to Reviewers 20248
Interobserver agreement in the interpretation of anal cytology8
Mitosis‐Karyorrhexis Index evaluation by digital image visual analysis for application of International Neuroblastoma Pathology Classification in FNA biopsy7
Is Milan for kids?: The Milan System for Reporting Salivary Gland Cytology in pediatric patients at an academic children's hospital with cytologic‐histologic correlation7
IDK what's next for IDC: The unfolding saga of intraductal carcinoma of salivary glands7
Next‐generation sequencing in the evaluation of biliary strictures in patients with primary sclerosing cholangitis7
RNA extended interventional nucleic acid longitudinal study: Clinical performance of Aptima messenger RNA HPV testing in cervical cancer screening with a 9‐year follow‐up7
Secretory carcinoma of the salivary gland, a rare entity: An international multi‐institutional study7
Analysis of the sensitivity of high‐grade squamous intraepithelial lesion Pap diagnosis and interobserver variability with the Hologic Genius Digital Diagnostics System7
Evaluating Diff‐Quik cytology smears for large‐panel mutation testing in lung cancer—Predicting DNA content and success with low‐malignant‐cellularity samples7
Spotlight: Rising stars in cytology7
The new endocrine WHO classification: What does this mean for thyroid cytology?7
Comprehensive epithelial biomarker analysis of malignant mesothelioma: EpCAM positivity is a potential diagnostic pitfall6
Spotlight: Rising stars in cytology6
6
6
Diagnostic features of low‐ and high‐grade mucinous neoplasms in pancreatic cyst FNA cytology6
Challenges in recognizing urothelial carcinoma in situ with plasmacytoid features by urinary cytology6
Role of EBUS‐TBNA/EUS‐FNA and mass spectrometry for diagnosis and typing of lymph node amyloidosis: 10‐year experience in two tertiary care academic centers6
Evaluation and diagnostic value of next‐generation sequencing analysis of residual liquid‐based cytology specimens of pancreatic masses6
6
Role of renal mass biopsy for diagnosis and management: Review of current trends and future directions6
Evaluating artificial intelligence–enhanced digital urine cytology for bladder cancer diagnosis6
Papillae, psammoma bodies, and/or many nuclear pseudoinclusions are helpful criteria but should not be required for a definitive cytologic diagnosis of papillary thyroid carcinoma: An institutional ex6
Disparities in cervical cancer screening in the United States6
Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next‐generation sequencing acquired by endoscopic ultrasound–guided FNA and FNB6
Prediction of lymph node status in patients with surgically treated head and neck squamous cell carcinoma via neck lavage cytology: A pilot study5
Cytology should create structured data sets without using synoptic reporting5
Marshalling the senses for a good night's sleep5
The digital expression profile of BMP7, CDKN2C, HIST1H3G, and PKMYT1 genes improves high‐grade cervical lesion detection in liquid‐based cytology5
Spotlight: Rising stars in cytology5
5
Minimizing mistakes through a culture of communication5
Quantifying the hidden impact of COVID‐19 pandemic: The cytology perspective5
5
5
Efficacy of Cobas HPV testing for predicting grade 2+ cervical intraepithelial neoplasia in a cancer prevention center and a gynecologic oncology clinic: A single‐institution experience5
Grading medullary thyroid carcinoma on fine‐needle aspiration cytology specimens with the International Medullary Thyroid Carcinoma Grading System: A cytologic–histologic correlation5
Insights on recent innovations in bladder cancer immunotherapy5
Error rates in cytology clinical history are correlated with the number of “clicks“ needed to obtain it5
Utility of high‐risk HPV RNA chromogenic in situ hybridization in cytology smears and liquid‐based preparations from metastatic head and neck squamous cell carcinoma4
Salivary duct carcinoma: A report of 70 FNA cases and review of the literature4
Lymph node FNA cytology: Diagnostic performance and clinical implications of proposed diagnostic categories4
Utility of the Milan System for Reporting Salivary Gland Cytology, with focus on the incidence and histologic correlates of atypia of undetermined significance (AUS) and salivary gland neoplasm of unc4
Issue Information4
The “preexisting condition” invention in American health care: A lingering threat to preventive care4
Evaluation of the pivot to digital teaching and learning in pathology: Sentiments from a low‐middle‐income country4
Combining molecular testing and the Bethesda category III:VI ratio for thyroid fine‐needle aspirates: A quality‐assurance metric for evaluating diagnostic performance in a cytopathology laboratory4
Prioritizing parotid gland surgery: A call for the implementation of the MSRSGC classification4
Cytologic diagnosis of metastatic melanoma by FNA: A practical review4
Giant cell tumor of soft tissue: FNA cytopathology of 4 cases, review of the literature, and comparison with giant cell tumor of bone4
Atypia of undetermined significance and ThyroSeq v3–positive call rates as quality control metrics for cytology laboratory performance4
The impact of different fixatives on immunostaining of lung adenocarcinomas in pleural effusion cell blocks4
Issue Information4
Cytomorphologic and molecular characterization of spindle cell carcinoid tumors of the lung4
Issue Information4
Utilization of an artificial intelligence–enhanced, web‐based application to review bile duct brushing cytologic specimens: A pilot study4
Risks of malignancy in the major nongynecologic cytopathology reporting systems: Critiques and discussions4
Improving the Pap test with artificial intelligence4
Scrutinizing high‐risk patients from ASC‐US cytology via a deep learning model4
Risk stratification of cytologically indeterminate thyroid nodules with nondiagnostic or benign cytology on repeat FNA: Implications for molecular testing and surveillance4
Incorporation of DNA methylation profiling into the cytopathology laboratory4
Editorial in response to Thangaiah et al.4
Metastatic germ cell tumors in serous cavities and cerebrospinal fluid: A single‐center experience4
Adrenal gland cytology reporting: a multi‐institutional proposal for a standardized reporting system4
Comparison of the Hologic Genius Digital Diagnostics System with the ThinPrep Imaging System—A retrospective assessment4
Probability of malignancy and molecular alterations as determined by ThyroSeq v3 genomic classifier in Bethesda Category IV4
0.061653852462769